Author:
Revilla R,Revilla M,Villa L.F,Cortés J,Arribas I,Rico H
Subject
Obstetrics and Gynecology,General Biochemistry, Genetics and Molecular Biology
Reference29 articles.
1. Preventive effects of clomifene citrate on estrogen-deficiency osteopenia elicited by LHRH agonist administration in the rat;Goulding;J Bone Miner Res,1991
2. Bone loss during gonadotropin-releasing hormone agonist treatment in girls with true precocious puberty is not due to an impairment of calcitonin secretion;Saggese;J Endocrinol Invest,1991
3. Is it possible to prevent bone loss in young women treated with luteinizing hormone-releasing hormone agonist?;Riis;J Clin Endocrinol Metab,1990
4. Hypogonadism induced by luteinising hormone releasing hormone agonist analogues: effects on bone density in premenopausal women;Matta;Br Med J,1987
5. Cann CE, Henzl M, Burry K, Andreyko J, Hanson F, Adamson GD, Trobough G, Henrichs L, Stewart G. Reversible bone loss is produced by the GnRH agonist nafarelin. In: Cohn DV, Martin TJ, Meunier JP, editors. Calcium Regulation and Bone Metabolism, vol. 9. Amsterdam: Excerpta Medica, 1987:123–127.
Cited by
25 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献